We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
МОЛЕКУЛЯРНО;ГЕНЕТИЧНІ ФЕНОТИПИ РАКУ МОЛОЧНОЇ ЗАЛОЗИ, ЇХ ПРОЛІФЕРАТИВНА АКТИВНІСТЬ, СТУПІНЬ РОЗПОВСЮДЖЕНОСТІ І ДИФЕРЕНЦІЮВАННЯ У ПАЦІЄНТІВ, ЯКІ ПОСТРАЖДАЛИ ВІД АВАРІЇ НА ЧАЕС
- Authors
Базика, Д. А.; Литвиненко, О. О.
- Abstract
Objective: analysis of molecular genetic phenotypes, their proliferative activity, degree of spread and differentiation of tumors in breast cancer patients affected by the accident at the Chornobyl Nuclear Power Plant. Materials and methods. 96 breast cancer patients who were exposed to ionizing radiation as a result of the acci dent at the Chornobyl Nuclear Power Plant were examined. Clinical, radiological, instrumental, morphological, immunohistochemical research methods were used. Results and conclusions. In patients who have been exposed to radiation, the frequency with which the molecular genetic phenotypes of breast cancer occur is somewhat different from the generally known data. Thus, luminal A phenotype was diagnosed in 17.7 %, luminal B in 56.2 %, HER2/neu expressing in 6.2 % and triple negative (TN) phenotype in 19.8 % patients. Proliferative activity indicators on average in patients with luminal A phenotype were at the level of 12.7 %, luminal B - 41.5 %, triple negative - 55.6 %, and HER2/neu positive breast cancer - 32.5 %. Patients with different molecular genetic phenotypes are diagnosed with different prevalence values of the TNM criteria. Metastatic lesions of regional lymph nodes (LNs) were diagnosed in 97.9 % of patients belonging to all phe notypes of breast cancer. Ki 67 values that did not exceed 20 % were found in 22.9 % of patients, the main number - 17.7 % had the luminal A subtype. In 77.1 % of patients, Ki 67 values were beyond 20 %, which indicates a more aggressive course of the disease in the majority of patients, which included patients with various molecular genetic subtypes, except for luminal A. A high degree of differentiation of mammary gland tumors was diagnosed in 8.3 % of patients. The main number of them, 6.2 %, had the luminal A phenotype. A moderate degree of differentiation was found in 65.6 %, where 43.7 % of patients had a luminal B HER2/neu negative phenotype. A low degree of differentiation was diagnosed in 26 % of patients, among whom 12.5 % were diagnosed with TN, and 9.4 % had a lumi& nal B HER2/neu negative phenotype.
- Subjects
NUCLEAR power plant accidents; NUCLEAR power plants; IONIZING radiation; BREAST cancer; MAMMARY glands
- Publication
Problems of Radiation Medicine & Radiobiology, 2024, Issue 29, p295
- ISSN
2304-8336
- Publication type
Academic Journal
- DOI
10.33145/2304-8336-2024-29-295-310